Hematology

Filter

gene therapy

EAHAD 2026: Nine-Year Outcomes of Gene Therapy

February 2026

Nine-year data show sustained safety and reduced bleeding after gene therapy in haemophilia B, although enrichment for full viral capsids did not deliver clear clinical advantages.

Updates on Isatuximab in Relapsed/Refractory and Newly Diagnosed Multiple Myeloma

In the past decade, therapies that are more effective and less toxic have transformed the treatment landscape for patients with MM…

Atorvastatin, Aspirin, and Hydroxyurea Treating Polycythaemia Vera

The following highlights focus on several insightful and innovative abstracts at the European Hematology Association (EHA) 2022 hybrid…

Optimising Outcomes in Cutaneous T Cell Lymphoma: Role of Blood Involvement and Treatment Options

CTCL is a rare type of non-Hodgkin lymphoma, primarily presenting in the skin but with extracutaneous involvement in some patients. Around…

Genome Editing and CAR-T Cell Therapy

Recent efforts to incorporate genome editing into CAR T cell therapy offers novel opportunities for treatment of haematologic malignancies…

Can 3D-Printed Blood Plasma Improve Wound Healing?

3D-printed PRP implant demonstrated its ability to improve the speed of wound healing through enabling increasingly efficient vascularisation

Second Untreated Patient with HIV Achieves Sterilising Cure

Team have now reported a second patient with no intact HIV viral sequences found in the analysis of more than 1.19 billion blood cells

Factor XI Inhibition: The Holy Grail of Haemostasis-Sparing Anticoagulation

Ajay Kakkar opened this virtual meeting by discussing the history of the treatment and prevention of thrombosis…

Sickle Cell Disease: More Than Just Anaemia

Rachel Kesse-Adu highlighted that the hallmark of sickle cell disease (SCD) is painful vaso-occlusive crises (VOCs). These not only cause…

Loading posts...

« Previous 1 … 60 61 62 63 64 … 100 Next »